Regulatory and clinical aspects of the resurgence of compounding by pharmacists.
During the past decade there has been a significant increase in the number of pharmacists in the United States who devote a substantial part of their professional activities to compounding prescription, in some instances for a wide variety of drugs and drug delivery systems.
There is dispute about the legal status of some of these activities.
Also, the clinical safety and efficacy of some of these products may be open to question.
The present paper explores issues involved in the present debate.
Mots-clés Pascal : Pharmacien, Pratique professionnelle, Législation, Réglementation, Assurance qualité, Etats Unis, Amérique du Nord, Amérique, Préparation pharmaceutique
Mots-clés Pascal anglais : Chemist, Professional practice, Legislation, Regulation, Quality assurance, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0336679
Code Inist : 002B30A05. Création : 10/04/1997.